Editorially curated · qa-sidra-pediatric-oncology-qatar
Sidra Pediatric Oncology Qatar
National pediatric precision-oncology program pairing tumor and germline multi-omics with a registry, biorepository, rapid genomic profiling, pharmacogenomics, and experimental therapies.
01 / Project overview
What the record establishes.
- Geographic scope
- Qatar national pediatric cancer catchment with regional cohort expansion
- Project type
- precision-oncology program, registry, and biorepository
- Research domain
- pediatric cancer genomics and precision medicine
- Years
- Not stated
- Lifecycle status
- active
- Status basis
- Sidra's current program page describes ongoing molecular profiling, an active pediatric cancer registry/biorepository, annual reports, and a pharmacogenomics trial.
- Status evidence date
- 2026-08-15
- Scale
- Expected 35-50 children per year, roughly half of Qatar's pediatric cancer cases; current focus includes acute lymphoblastic leukemia and central-nervous-system tumors.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Sidra Medicine
- Partner organizations
- Children's Oncology Group · International Society of Paediatric Oncology · regional institutions in Pakistan, Jordan, and Turkey
- Organism / population
- Children with suspected or diagnosed cancer
03 / Data and access
What exists and how it can be reached.
Data types
- tumor whole-genome sequencing
- germline sequencing
- whole-transcriptome sequencing
- epigenetic profiling
- long reads
- spatial/single-cell assays
- liquid biopsy
- clinical registry
- biospecimens
- pharmacogenomics
Data access
Clinical/research program; annual aggregate precision-oncology reports are public, participant-level data controlled.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
National, continuously recruited cancer-genomics cohort with durable registry and biorepository infrastructure.
Editorial note
SPOQ's registry, biorepository, eGOP workflow, and PGx trial are treated as one program rather than separate records.
Sources
- primary record source Verified 2026-08-15
Release v0.2.0